Based on cancer gene mutation clustering, we could find a group of subtypes (mainly prostate and brain tumors) that are characterized by overall co-downregulation of GPCR axes and concomitant mutations of several tumor suppressor genes (TSGs). The gene discussed is LPAR3; the disease is cancer.